H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Immunology D-index 55 Citations 11,294 159 World Ranking 2267 National Ranking 8

Overview

What is he best known for?

The fields of study he is best known for:

  • Immune system
  • Internal medicine
  • Gene

Thomas J. Scriba mostly deals with Tuberculosis, Immunology, Mycobacterium tuberculosis, Vaccination and Tuberculosis vaccines. Thomas J. Scriba works on Tuberculosis which deals in particular with BCG vaccine. His studies examine the connections between Immunology and genetics, as well as such issues in Virology, with regards to Immunity.

His biological study spans a wide range of topics, including Seroconversion, Antigen and Cohort. His Vaccination study combines topics in areas such as Inflammation and Myeloid. His study explores the link between Tuberculosis vaccines and topics such as Clinical trial that cross with problems in Adverse effect.

His most cited work include:

  • Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial (729 citations)
  • Identifying specificity groups in the T cell receptor repertoire (403 citations)
  • A blood RNA signature for tuberculosis disease risk: a prospective cohort study. (397 citations)

What are the main themes of his work throughout his whole career to date?

Thomas J. Scriba mainly investigates Tuberculosis, Immunology, Mycobacterium tuberculosis, Immune system and Vaccination. Thomas J. Scriba has researched Tuberculosis in several fields, including Internal medicine, Disease and Cohort. His Immunology study integrates concerns from other disciplines, such as Cytotoxic T cell and Virology.

His studies in Mycobacterium tuberculosis integrate themes in fields like Innate immune system, Immunopathology and Immunity. He has included themes like Tumor necrosis factor alpha, Whole blood and Cytokine in his Immune system study. Thomas J. Scriba has included themes like Adverse effect and Randomized controlled trial in his Vaccination study.

He most often published in these fields:

  • Tuberculosis (68.07%)
  • Immunology (61.34%)
  • Mycobacterium tuberculosis (50.00%)

What were the highlights of his more recent work (between 2019-2021)?

  • Tuberculosis (68.07%)
  • Immunology (61.34%)
  • Mycobacterium tuberculosis (50.00%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Tuberculosis, Immunology, Mycobacterium tuberculosis, Immune system and Disease. His biological study spans a wide range of topics, including MEDLINE, Environmental health, Immunopathology, Biomarker and Cohort. His research on Immunology frequently connects to adjacent areas such as Respiratory tract.

His Mycobacterium tuberculosis research includes elements of Chemokine, T cell, Area under the curve and Antigen. His Immune system study also includes fields such as

  • Tumor necrosis factor alpha, which have a strong connection to CD8 and Molecular biology,
  • Gene, which have a strong connection to Epitope and Human leukocyte antigen. Thomas J. Scriba usually deals with Disease and limits it to topics linked to Asymptomatic and CD3.

Between 2019 and 2021, his most popular works were:

  • Analyzing the Mycobacterium tuberculosis immune response by T-cell receptor clustering with GLIPH2 and genome-wide antigen screening. (36 citations)
  • RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response (16 citations)
  • S100A8/A9 regulates CD11b expression and neutrophil recruitment during chronic tuberculosis (13 citations)

In his most recent research, the most cited papers focused on:

  • Immune system
  • Gene
  • Internal medicine

Thomas J. Scriba mainly focuses on Mycobacterium tuberculosis, Tuberculosis, Immunology, Immune system and Disease. His work in Mycobacterium tuberculosis is not limited to one particular discipline; it also encompasses Genome. His work carried out in the field of Tuberculosis brings together such families of science as Biomarker and Immunopathology.

His Immunology study focuses on Vaccination in particular. His Immune system research is multidisciplinary, relying on both Tumor necrosis factor alpha, Gene and Antigen. His Disease research is multidisciplinary, incorporating elements of Oncology, Venous blood, Positron emission tomography, Subclinical infection and Cohort.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial

Michele D Tameris;Mark Hatherill;Bernard S Landry;Thomas J Scriba.
The Lancet (2013)

970 Citations

Immunological biomarkers of tuberculosis.

Gerhard Walzl;Katharina Ronacher;Willem Hanekom;Thomas J. Scriba.
Nature Reviews Immunology (2011)

532 Citations

Distinct, Specific IL-17- and IL-22-Producing CD4+ T Cell Subsets Contribute to the Human Anti-Mycobacterial Immune Response

Thomas J. Scriba;Barbara Kalsdorf;Deborah-Ann Abrahams;Fatima Isaacs.
Journal of Immunology (2008)

485 Citations

Identifying specificity groups in the T cell receptor repertoire

Jacob Glanville;Huang Huang;Allison Nau;Olivia Hatton.
Nature (2017)

436 Citations

A blood RNA signature for tuberculosis disease risk: a prospective cohort study.

Daniel E Zak;Adam Penn-Nicholson;Thomas J Scriba;Ethan Thompson.
The Lancet (2016)

423 Citations

Specific T Cell Frequency and Cytokine Expression Profile Do Not Correlate with Protection against Tuberculosis after Bacillus Calmette-Guérin Vaccination of Newborns

Benjamin M. N. Kagina;Brian Abel;Thomas J. Scriba;Elizabeth J. Hughes.
American Journal of Respiratory and Critical Care Medicine (2010)

403 Citations

Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination

Elisa Nemes;Hennie Geldenhuys;Virginie Rozot;Kathryn T Rutkowski.
The New England Journal of Medicine (2018)

308 Citations

Bacillus Calmette-Guérin Vaccination of Human Newborns Induces T Cells with Complex Cytokine and Phenotypic Profiles

Andreia P. Soares;Thomas J. Scriba;Sarah Joseph;Ryhor Harbacheuski.
Journal of Immunology (2008)

261 Citations

T cells and adaptive immunity to Mycobacterium tuberculosis in humans

Luke D. Jasenosky;Thomas J. Scriba;Willem A. Hanekom;Willem A. Hanekom;Anne E. Goldfeld.
Immunological Reviews (2015)

250 Citations

Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells

Thomas J. Scriba;Michele Tameris;Nazma Mansoor;Erica Smit.
European Journal of Immunology (2009)

243 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Thomas J. Scriba

Alessandro Sette

Alessandro Sette

La Jolla Institute For Allergy & Immunology

Publications: 158

Robert J. Wilkinson

Robert J. Wilkinson

The Francis Crick Institute

Publications: 124

Helen McShane

Helen McShane

University of Oxford

Publications: 90

Tom H. M. Ottenhoff

Tom H. M. Ottenhoff

Leiden University Medical Center

Publications: 85

Bjoern Peters

Bjoern Peters

La Jolla Institute For Allergy & Immunology

Publications: 84

Mihai G. Netea

Mihai G. Netea

Radboud University Nijmegen

Publications: 76

Gerhard Walzl

Gerhard Walzl

Stellenbosch University

Publications: 66

Stefan H. E. Kaufmann

Stefan H. E. Kaufmann

Max Planck Institute for Infection Biology

Publications: 62

Paul Klenerman

Paul Klenerman

University of Oxford

Publications: 60

Delia Goletti

Delia Goletti

Istituto Sperimentale Italiano Lazzaro Spallanzani

Publications: 53

Hazel M. Dockrell

Hazel M. Dockrell

London School of Hygiene & Tropical Medicine

Publications: 48

Alimuddin Zumla

Alimuddin Zumla

University College London

Publications: 46

Carlos Martín

Carlos Martín

Instituto de Salud Carlos III

Publications: 45

Katalin A. Wilkinson

Katalin A. Wilkinson

The Francis Crick Institute

Publications: 44

Jamie Rossjohn

Jamie Rossjohn

Monash University

Publications: 41

John Sidney

John Sidney

La Jolla Institute For Allergy & Immunology

Publications: 41

Something went wrong. Please try again later.